169 related articles for article (PubMed ID: 33004260)
1. Conundrums in leishmaniasis.
Saha B; Bhattacharjee S; Sarkar A; Bhor R; Pai K; Bodhale N
Cytokine; 2021 Sep; 145():155304. PubMed ID: 33004260
[TBL] [Abstract][Full Text] [Related]
2. In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.
Sengupta R; Mukherjee S; Moulik S; Mitra S; Chaudhuri SJ; Das NK; Chatterjee U; Chatterjee M
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():166-176. PubMed ID: 31542359
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
[TBL] [Abstract][Full Text] [Related]
4. Cytokines in the immunity and immunopathogenesis in leishmaniases.
Saha B; Silvestre R
Cytokine; 2021 Sep; 145():155320. PubMed ID: 33127260
[TBL] [Abstract][Full Text] [Related]
5. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
6. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
Zijlstra EE
Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
[TBL] [Abstract][Full Text] [Related]
7. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
[TBL] [Abstract][Full Text] [Related]
8. Permissive and protective roles for neutrophils in leishmaniasis.
Carlsen ED; Liang Y; Shelite TR; Walker DH; Melby PC; Soong L
Clin Exp Immunol; 2015 Nov; 182(2):109-18. PubMed ID: 26126690
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.
Soong L; Henard CA; Melby PC
Semin Immunopathol; 2012 Nov; 34(6):735-51. PubMed ID: 23053396
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
Salotra P; Singh R
Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
[TBL] [Abstract][Full Text] [Related]
11. Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis.
Mukherjee S; Mukhopadhyay D; Braun C; Barbhuiya JN; Das NK; Chatterjee U; von Stebut E; Chatterjee M
Exp Dermatol; 2015 Mar; 24(3):232-4. PubMed ID: 25580856
[TBL] [Abstract][Full Text] [Related]
12. Neutrophils and Visceral Leishmaniasis: Impact on innate immune response and cross-talks with macrophages and dendritic cells.
Kupani M; Pandey RK; Mehrotra S
J Cell Physiol; 2021 Apr; 236(4):2255-2267. PubMed ID: 33345353
[TBL] [Abstract][Full Text] [Related]
13. Lesional T-cell subset in post-kala-azar dermal leishmaniasis.
Rathi SK; Pandhi RK; Chopra P; Khanna N
Int J Dermatol; 2005 Jan; 44(1):12-3. PubMed ID: 15663651
[TBL] [Abstract][Full Text] [Related]
14. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
[TBL] [Abstract][Full Text] [Related]
15. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
[TBL] [Abstract][Full Text] [Related]
16. Post-kala-azar dermal leishmaniasis--an overview.
Ganguly S; Das NK; Barbhuiya JN; Chatterjee M
Int J Dermatol; 2010 Aug; 49(8):921-31. PubMed ID: 21128917
[TBL] [Abstract][Full Text] [Related]
17. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
[TBL] [Abstract][Full Text] [Related]
18. Animal models for the analysis of immune responses to leishmaniasis.
Sacks DL; Melby PC
Curr Protoc Immunol; 2015 Feb; 108():19.2.1-19.2.24. PubMed ID: 25640990
[TBL] [Abstract][Full Text] [Related]
19. Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.
Mukherjee S; Mukhopadhyay D; Ghosh S; Barbhuiya JN; Das NK; Chatterjee M
J Clin Immunol; 2016 Jan; 36(1):85-94. PubMed ID: 26644312
[TBL] [Abstract][Full Text] [Related]
20. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
Katara GK; Ansari NA; Singh A; Ramesh V; Salotra P
PLoS Negl Trop Dis; 2012; 6(6):e1703. PubMed ID: 22724038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
